$72.10

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI01945_25_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
2'-Deoxycytidine
Brand Name
Chem Impex
Product Number
01945
CAS
951-77-9
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
13711
IUPAC Name
4-amino-1-(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-ylpyrimidin-2-one
InChI Key
CKTSBUTUHBMZGZ-SHYZEUOFSA-N
SMILES
C1C@@H(C@H(OC@H1N2C=CC(=NC2=O)N)CO)O

Application

2'-Deoxycytidine is widely utilized in research focused on:

DNA Synthesis: It serves as a building block for DNA, making it essential in genetic engineering and molecular biology applications.

Antiviral Research: This compound is explored for its potential in developing antiviral therapies, particularly against viruses like HIV and hepatitis.

Cancer Treatment: Researchers investigate its role in chemotherapy regimens, as it can be incorporated into DNA and affect cancer cell proliferation.

Genetic Studies: It is used in studies involving DNA replication and repair mechanisms, providing insights into genetic disorders and aging.

Pharmaceutical Development: The compound is a key ingredient in the formulation of nucleoside analogs, which are crucial for developing new medications.

References

Human serum hypoxanthine as a biomarker to predict recurrent major depressive disorder: a cross-sectional metabolomic study

Publication Name: Metabolic Brain Disease
Publication Date: 2026-02-24
DOI: 10.1007/s11011-026-01810-2

Targeting Metabolic Vulnerabilities in Glioblastoma: a Framework for Multi-node Combination Therapy

Publication Name: Current Oncology Reports
Publication Date: 2026-02-20
DOI: 10.1007/s11912-026-01746-x

Untargeted metabolomics profiling of childhood asthma: linking metabolic pattern to disease severity

Publication Name: Molecular and Cellular Pediatrics
Publication Date: 2026-02-16
DOI: 10.1186/s40348-026-00219-2

NRXN3 regulates pyroptosis in intrahepatic cholangiocarcinoma via mediating the phospho-dependent ubiquitination and degradation of caspase-3

Publication Name: Journal of Advanced Research
Publication Date: 2026-02
DOI: 10.1016/j.jare.2025.04.040

Doxecitine and Doxribtimine: First Approval

Publication Name: Paediatric drugs
Publication Date: 2026-01-28
DOI: 10.1007/s40272-025-00734-1